Isabel Kloer MD MSc is Senior Clinical Program Leader at Boehringer Ingelheim, responsible for several registrational trials within the obesity portfolio. As a physician scientist, she has for over 20 years enjoyed leading across a variety of functions in the pharmaceutical industry, bringing together clinical experience in internal medicine with drug and device safety, digital product development, and clinical trials in metabolic and respiratory disease.